On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

Sure signs of fall in Utah County include the blaze of magnificent colors in the surrounding mountains, packed football ...

Vaccines delivered through a spray into the nose could offer better protection and fewer side effects than traditional vaccine shots in the arm.

A variety of medical device innovations and diagnostics have been named by Time as some of the best inventions of 2024.

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections (uUTIs). Orlynvah (sulopenem etzadroxil and probenecid) is a broad-spectrum ...

There are currently nine different flu vaccines approved by the Food and Drug Administration (FDA) that fall under two categories ... As a rule, people undergoing cancer treatment should never receive ...

Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

The American Clinical Laboratory Association and the Association for Molecular Pathology sued the FDA, claiming regulatory overreach, in a case that has been consolidated in the U.S. District ...

Former President Rodrigo Duterte was defiant in Senate testimony about the years of bloodshed that left thousands dead. “I did it for my country,” he said. By Sui-Lee Wee and Aie Balagtas See ...

The FDA has approved the at-home use of FluMist, a nasal spray flu vaccine, available in fall 2025. Effective for healthy people aged 2 to 49, it offers a needle-free option but isn't suitable for ...